Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are a class of antidiabetic drugs developed over the past 15 years. GLP-1, a gastrointestinal peptide hormone that contributes to the postprandial “incretin effect”, stimulates glucose-dependent insulin secretion. The i...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a1353861504246f5877ed418350e4d42 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!